Statement: murine monoclonal antibody d612 is a murine monoclonal antibody directed against human colorectal carcinoma-associated cell-surface antigen d612. (nci04) the primary trial and the secondary trial do not record any cardiac or infection related adverse events, but they both record several instances of epilepsy.
Primary_evidence: Adverse Events 1:   Total: 0/655 (0.00%) Adverse Events 2:   Total: 0/580 (0.00%)
Secondary_evidence: Adverse Events 1:   Total: 0/15 (0.00%) Adverse Events 2:   Total: 0/16 (0.00%)